|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_RelatedPartyTransactionsAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
-Unofficial Translation- The transactions carried out between Salutem Ecza Deposu Medikal Ltd. Şti. (Salutem) and GEN, one of the related parties of our Company, were examined in accordance with article 10 of the "Capital Markets Board of Türkiye Corporate Governance Communiqué" and a report was prepared by the Board of Birectors stating that the transactions made between Salutem and GEN are in line with the precedent The summary of the commercial relations and the evaluation result are submitted below. Commercial Relation Between The GEN and The Salutem Salutem is authorized by our Company in order to participate tenders held by institutions such as "The State Supply Office" for drugs imported and produced by GEN. Based on this authorization, it participates to tenders and if it wins the tender, it procures the products subject to tender from our Company and delivers them to the requesting institution. Two tenders won by Salutem in 2023 and summarized information regarding tenders presented below. Salutem won a tender held by The State Supply Office on 07.11.2023 and contribution of this tender to GEN's total sales is approximately TL 402.000.000,00 (Four Hundred Two Million Turkish Liras) Salutem won a tender held by The State Supply Office on 22.11.2023 and contribution of this tender to GEN's total sales is approximately TL 900.000,00 (Nine Hundred Thousand Turkish Liras) Result
Compliance of the transactions between GEN and Salutem to the precedents was evaluated according to the article 10 of the Corporate Governance Comminuque. As a result of this evaluation it has been determined that prices of the drugs which sold to Salutem are compliant with the prices which of the other companies which commercial relation carried out by our Company.
In addition, in transactions carried out with Salutem, GEN's profitability is determined in accordance with the transactions made with institutions authorized by our Company in previous periods. Within this framework necessary actions were taken to preserve commercial traditions and company interest at highest level. |
||||||||